The convergence of nanotechnology and nucleic acid delivery systems represents a paradigm shift in modern medicine. Traditional drug delivery mechanisms face significant challenges, such as poor bioavailability, limited targeting capabilities, and adverse side effects. Nanotechnology offers innovative solutions to these obstacles, enabling the development of effective delivery vehicles. This book explores the intricate interplay between nanotechnology and genetic medicine, offering insights into the latest advancements, methodologies, and applications.
The book covers a broad spectrum of topics, from the fundamental principles of nanotechnology and nucleic acid chemistry to the design, synthesis, and characterization of various nanocarriers. Special attention is given to the practical aspects of developing nanotechnology-based delivery systems, including scalability, regulatory considerations, and clinical translation.
The volume discusses the challenges in nucleic acid delivery, the role of polymers in nucleic acid delivery, the regulatory aspects related to nanomedicine and gene therapy applications, the role of artificial intelligence in optimizing nanocarriers for nucleic acid delivery, the application of AI and nanotechnology for personalized cancer care by nucleic acid delivery, as well as case studies and success stories of AI-driven approaches for nucleic acid delivery
Explores the intricate interplay between nanotechnology and genetic medicine, offering insights into the latest advancements, methodologies, and applications. Covers various topics, from the fundamental principles of nanotechnology and nucleic acid chemistry to the design, synthesis, and characterization of various nanocarriers.
Introduction
1. An Overview of Nanomedicine and Its Potentials in the
Revolutizing Healthcare
2. Current Advancements and Upcoming Possibilities of
Nanotechnology in Nucleic Acid Delivery
3. Challenges in Nucleic Acid
Delivery
4. Role of Polymers in Nucleic Acid Delivery
5. Regulatory Aspects
Related to Nano Medicine and Gene Therapy Applications
6. Fundamentals of
Artificial Intelligence
7. Role of Artificial Intelligence in Optimizing
Nanocarriers for Nucleic Acid Delivery
8. Future Possibilities for
Integrating AI with Nano-Carrier Technology
9. Case Studies and Success
Stories of AI-Driven Approaches for Nucleic Acid Delivery
10. Obstacles to
Combining Artificial Intelligence with Nanotechnology for Nucleic Acid
Delivery
11. Nanotechnology and AI: Implications for Future of Personalized
Cancer Care by Nucleic Acid Delivery
12. Nanobotic Intelligence: Optimizing
Nucleic Acid Delivery with AI
Pankaj Sharma, PhD, is a Professor of Pharmaceutics at the Shri Ram College of Pharmacy, Banmore, Madhya Pradesh, India. He is actively involved in formulating nanocarriers for effective delivery of drugs for the treatment of malaria, arthritis, etc. Dr. Sharma has received many awards and prizes for his contributions. He has been an invited speaker at conferences, seminars, symposiums, and workshops and participates on a number of university, department, and institute committees. He has produced peer-reviewed papers in the field of pharmaceutical sciences, along with book chapters. He is also a reviewer for several international scientific publications.
Saloni Jain, PhD, is an Associate Professor of Pharmacology at the Shri Ram College of Pharmacy, Banmore, Madhya Pradesh, India. Her research interests focus on the development of herbal preparations and antidiabetic activities for effective drug delivery, specifically for skin diseases, diabetes, and diuretics. Dr. Jain has presented research papers at international conferences and has been granted a UK patent design. She is an active participant in various universities, departments, and institute committees and has published several book chapters and research and review papers in national and international journals.
Vinay Jain, PhD, is the Principal of Shri Ram College of Pharmacy, Banmore, Madhya Pradesh, India. He has made significant contributions to the field through his research and publications, including peer-reviewed articles, edited and indexed books, and guidance for over 30 research scholars. Dr. Jain is an active member of the pharmacy community, serving as co-convener of the Indo-Caribbean conference and organizing secretary of the Future Prospect in Pharma-Marketing national conference. He has been recognized for his leadership and mentorship in the field. He has filed two patents and published many papers in international and national journals.
